Prospective, randomized, controlled pilot study of partial liquid ventilation in adult acute respiratory distress syndrome

Ronald B. Hirschl, Martin Croce, Dennis Gore, Herbert Wiedemann, K. E N Davis, Joseph Zwischenberger, Robert H. Bartlett

Research output: Contribution to journalArticle

158 Citations (Scopus)

Abstract

We evaluated the safety and efficacy of partial liquid ventilation (PLV) with perflubron in adult patients with acute lung injury and the acute respiratory distress syndrome (ARDS) in a multicenter, prospective, controlled, randomized exploratory clinical trial. Ninety adult patients with PaO2/F1O2 ratios > 60 and < 300 with ARDS for no more than 24 hours were randomized to receive PLV (n = 65) with administration of perflubron through an endotracheal tube sideport or conventional mechanical ventilation (CMV, n = 25) for a maximum of five days. Although a significant reduction in progression to ARDS was noted among patients with PLV, no significant differences in the number of days free from the ventilator at 28 days (CMV = 6.7 ± 1.8, PLV = 6.3 ± 1.0 days, p = 0.85), the incidence of mortality (CMV = 36%, PLV = 42%, p = 0.63), or any pulmonary-related parameter were observed. During a post hoc subgroup analysis, significantly more rapid discontinuation of mechanical ventilation (p = 0.045) and a trend toward an increase in the number of days free from the ventilator at 28 days (CMV = 3.2 ± 1.9, PLV = 8.0 ± 2.2 days, p = 0.06) were observed during PLV among those patients under 55 years of age with acute lung injury or ARDS. Episodes of hypoxia, respiratory acidosis, and bradycardia occurred more frequently in the PLV group, but these were transient and self-limited. Further evaluation of PLV is warranted to further define beneficial effects in well-defined groups of patients and also to gain additional information regarding safety.

Original languageEnglish (US)
Pages (from-to)781-787
Number of pages7
JournalAmerican Journal of Respiratory and Critical Care Medicine
Volume165
Issue number6
StatePublished - Mar 15 2002

Fingerprint

Liquid Ventilation
Adult Respiratory Distress Syndrome
Acute Lung Injury
Mechanical Ventilators
Artificial Respiration
Respiratory Acidosis
Safety
Bradycardia
Randomized Controlled Trials

Keywords

  • Acute respiratory distress syndrome
  • Fluorocarbon
  • Liquid ventilation

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Prospective, randomized, controlled pilot study of partial liquid ventilation in adult acute respiratory distress syndrome. / Hirschl, Ronald B.; Croce, Martin; Gore, Dennis; Wiedemann, Herbert; Davis, K. E N; Zwischenberger, Joseph; Bartlett, Robert H.

In: American Journal of Respiratory and Critical Care Medicine, Vol. 165, No. 6, 15.03.2002, p. 781-787.

Research output: Contribution to journalArticle

Hirschl, Ronald B. ; Croce, Martin ; Gore, Dennis ; Wiedemann, Herbert ; Davis, K. E N ; Zwischenberger, Joseph ; Bartlett, Robert H. / Prospective, randomized, controlled pilot study of partial liquid ventilation in adult acute respiratory distress syndrome. In: American Journal of Respiratory and Critical Care Medicine. 2002 ; Vol. 165, No. 6. pp. 781-787.
@article{e8d7399a8f93437b9c07b2c14cd0e4c6,
title = "Prospective, randomized, controlled pilot study of partial liquid ventilation in adult acute respiratory distress syndrome",
abstract = "We evaluated the safety and efficacy of partial liquid ventilation (PLV) with perflubron in adult patients with acute lung injury and the acute respiratory distress syndrome (ARDS) in a multicenter, prospective, controlled, randomized exploratory clinical trial. Ninety adult patients with PaO2/F1O2 ratios > 60 and < 300 with ARDS for no more than 24 hours were randomized to receive PLV (n = 65) with administration of perflubron through an endotracheal tube sideport or conventional mechanical ventilation (CMV, n = 25) for a maximum of five days. Although a significant reduction in progression to ARDS was noted among patients with PLV, no significant differences in the number of days free from the ventilator at 28 days (CMV = 6.7 ± 1.8, PLV = 6.3 ± 1.0 days, p = 0.85), the incidence of mortality (CMV = 36{\%}, PLV = 42{\%}, p = 0.63), or any pulmonary-related parameter were observed. During a post hoc subgroup analysis, significantly more rapid discontinuation of mechanical ventilation (p = 0.045) and a trend toward an increase in the number of days free from the ventilator at 28 days (CMV = 3.2 ± 1.9, PLV = 8.0 ± 2.2 days, p = 0.06) were observed during PLV among those patients under 55 years of age with acute lung injury or ARDS. Episodes of hypoxia, respiratory acidosis, and bradycardia occurred more frequently in the PLV group, but these were transient and self-limited. Further evaluation of PLV is warranted to further define beneficial effects in well-defined groups of patients and also to gain additional information regarding safety.",
keywords = "Acute respiratory distress syndrome, Fluorocarbon, Liquid ventilation",
author = "Hirschl, {Ronald B.} and Martin Croce and Dennis Gore and Herbert Wiedemann and Davis, {K. E N} and Joseph Zwischenberger and Bartlett, {Robert H.}",
year = "2002",
month = "3",
day = "15",
language = "English (US)",
volume = "165",
pages = "781--787",
journal = "American Journal of Respiratory and Critical Care Medicine",
issn = "1073-449X",
publisher = "American Thoracic Society",
number = "6",

}

TY - JOUR

T1 - Prospective, randomized, controlled pilot study of partial liquid ventilation in adult acute respiratory distress syndrome

AU - Hirschl, Ronald B.

AU - Croce, Martin

AU - Gore, Dennis

AU - Wiedemann, Herbert

AU - Davis, K. E N

AU - Zwischenberger, Joseph

AU - Bartlett, Robert H.

PY - 2002/3/15

Y1 - 2002/3/15

N2 - We evaluated the safety and efficacy of partial liquid ventilation (PLV) with perflubron in adult patients with acute lung injury and the acute respiratory distress syndrome (ARDS) in a multicenter, prospective, controlled, randomized exploratory clinical trial. Ninety adult patients with PaO2/F1O2 ratios > 60 and < 300 with ARDS for no more than 24 hours were randomized to receive PLV (n = 65) with administration of perflubron through an endotracheal tube sideport or conventional mechanical ventilation (CMV, n = 25) for a maximum of five days. Although a significant reduction in progression to ARDS was noted among patients with PLV, no significant differences in the number of days free from the ventilator at 28 days (CMV = 6.7 ± 1.8, PLV = 6.3 ± 1.0 days, p = 0.85), the incidence of mortality (CMV = 36%, PLV = 42%, p = 0.63), or any pulmonary-related parameter were observed. During a post hoc subgroup analysis, significantly more rapid discontinuation of mechanical ventilation (p = 0.045) and a trend toward an increase in the number of days free from the ventilator at 28 days (CMV = 3.2 ± 1.9, PLV = 8.0 ± 2.2 days, p = 0.06) were observed during PLV among those patients under 55 years of age with acute lung injury or ARDS. Episodes of hypoxia, respiratory acidosis, and bradycardia occurred more frequently in the PLV group, but these were transient and self-limited. Further evaluation of PLV is warranted to further define beneficial effects in well-defined groups of patients and also to gain additional information regarding safety.

AB - We evaluated the safety and efficacy of partial liquid ventilation (PLV) with perflubron in adult patients with acute lung injury and the acute respiratory distress syndrome (ARDS) in a multicenter, prospective, controlled, randomized exploratory clinical trial. Ninety adult patients with PaO2/F1O2 ratios > 60 and < 300 with ARDS for no more than 24 hours were randomized to receive PLV (n = 65) with administration of perflubron through an endotracheal tube sideport or conventional mechanical ventilation (CMV, n = 25) for a maximum of five days. Although a significant reduction in progression to ARDS was noted among patients with PLV, no significant differences in the number of days free from the ventilator at 28 days (CMV = 6.7 ± 1.8, PLV = 6.3 ± 1.0 days, p = 0.85), the incidence of mortality (CMV = 36%, PLV = 42%, p = 0.63), or any pulmonary-related parameter were observed. During a post hoc subgroup analysis, significantly more rapid discontinuation of mechanical ventilation (p = 0.045) and a trend toward an increase in the number of days free from the ventilator at 28 days (CMV = 3.2 ± 1.9, PLV = 8.0 ± 2.2 days, p = 0.06) were observed during PLV among those patients under 55 years of age with acute lung injury or ARDS. Episodes of hypoxia, respiratory acidosis, and bradycardia occurred more frequently in the PLV group, but these were transient and self-limited. Further evaluation of PLV is warranted to further define beneficial effects in well-defined groups of patients and also to gain additional information regarding safety.

KW - Acute respiratory distress syndrome

KW - Fluorocarbon

KW - Liquid ventilation

UR - http://www.scopus.com/inward/record.url?scp=0037086002&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037086002&partnerID=8YFLogxK

M3 - Article

VL - 165

SP - 781

EP - 787

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

SN - 1073-449X

IS - 6

ER -